Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

CLYM vs GERN: stock comparison and AI forecast

Climb Bio, Inc. (CLYM) and Geron Corp (GERN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

CLYM Climb Bio, Inc.

Market Cap
$560M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

GERN Geron Corp

Price
$0.93 -40.8% · 6M
Market Cap
$598M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CLYM · GERN

Key facts

  • CLYM and GERN have similar market capitalizations ($560M and $598M).
  • GERN carries 1.53 times debt per unit of equity, against 0.03 times for CLYM.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCLYMGERN
Market Cap$560M$598M
P/B Ratio2.34x2.65x
EPS$-0.93$-0.13
Book Value/Share$4.17$0.35

Profitability & Margins

MetricCLYMGERN
ROE-24.1%-45.6%
ROA-23.4%–
ROIC-26.9%–
Operating Margin–-26.5%
Net Margin–-52.5%
EBT Margin–-34.0%
Tax Rate0.0%–

Financial Health

MetricCLYMGERN
Current Ratio31.45x6.92x
Quick Ratio–5.16x
D/E Ratio0.03x1.53x
Financial Leverage1.03x–
Interest Coverage–-2.2x
Working Capital$181M$416M

Cash Flow

MetricCLYMGERN
Operating Cash Flow-$53M-$114M

Income Statement

MetricCLYMGERN
Operating Income-$65M-$52M
Net Income-$58M-$103M
R&D Expense$42M$72M
SG&A Expense–$155M

Dividend & Shareholder Information

MetricCLYMGERN
Shares Outstanding57M642M
EPS Growth-720.0%–
FAQ

CLYM vs GERN: stock comparison and AI forecast

Which is bigger, CLYM or GERN?

CLYM and GERN have similar market capitalizations ($560M and $598M).

Which one does Intratio's AI model rank higher, CLYM or GERN?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.